Utah Medical Products - 20 Year Stock Price History | UTMD

Historical daily share price chart and data for Utah Medical Products since 1999 adjusted for splits. The latest closing stock price for Utah Medical Products as of October 18, 2019 is 95.83.
  • The all-time high Utah Medical Products stock closing price was 116.00 on June 20, 2018.
  • The Utah Medical Products 52-week high stock price is 102.46, which is 6.9% above the current share price.
  • The Utah Medical Products 52-week low stock price is 73.98, which is 22.8% below the current share price.
  • The average Utah Medical Products stock price for the last 52 weeks is 88.46.
Utah Medical Products Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 88.7423 84.7700 100.0000 77.7600 95.8300 15.35%
2018 94.3863 79.3000 116.0000 74.6400 83.0800 2.06%
2017 69.7137 71.4000 84.0500 58.8500 81.4000 11.89%
2016 63.0624 58.6600 72.7500 55.5100 72.7500 24.27%
2015 56.5516 57.8800 62.6900 50.6300 58.5400 -2.51%
2014 53.0068 51.7600 60.1300 47.0900 60.0500 5.06%
2013 49.9361 38.3200 63.7400 38.3200 57.1600 58.56%
2012 32.6495 27.3100 36.1600 26.9800 36.0500 33.52%
2011 26.8385 26.9850 29.3000 24.5200 27.0000 0.45%
2010 27.3865 29.5600 30.2600 24.4500 26.8800 -8.32%
2009 26.0745 23.9500 30.0000 21.1100 29.3200 33.58%
2008 27.7187 29.6000 30.9000 21.1600 21.9500 -26.14%
2007 31.7939 33.0000 34.5940 29.5000 29.7200 -9.88%
2006 31.5969 30.6000 34.5000 28.5000 32.9800 3.22%
2005 23.6948 22.2100 31.9500 20.1000 31.9500 42.19%
2004 23.1344 25.7100 27.0000 17.2600 22.4700 -14.04%
2003 21.1741 19.3100 26.1400 17.5000 26.1400 36.86%
2002 15.6694 13.2000 19.2800 12.5400 19.1000 40.34%
2001 10.5207 7.5000 13.7400 7.0310 13.6100 81.47%
2000 7.1738 6.4400 8.3750 6.0000 7.5000 11.11%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.354B $0.042B
Utah Medical Products is in the business of producing cost-effective devices for the healthcare industry which are predominantly proprietary, disposable and for hospital use. The company's success in rapidly producing solutions comes from its proven ability to integrate a number of engineering and technical disciplines in electronics, software, mechanical packaging, instrumentation, optics and materials. The resulting proprietary products represent significant incremental improvementsover existing clinical techniques.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $145.598B 26.57
Medtronic (MDT) Ireland $145.585B 20.43
Stryker (SYK) United States $80.642B 27.89
Boston Scientific (BSX) United States $53.170B 25.79
Baxter (BAX) United States $44.852B 27.20
EssilorLuxottica Societe Anonyme (ESLOY) France $32.725B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.438B 18.20
Coloplast (CLPBY) Denmark $25.747B 41.10
Lonza Group Ag (LZAGY) Switzerland $25.481B 0.00
Terumo (TRUMY) Japan $24.495B 30.57
Smith & Nephew SNATS (SNN) United Kingdom $20.928B 0.00
ResMed (RMD) United States $18.924B 36.06
Sunny Optical Technology (SNPTF) China $16.014B 0.00
Bio-Rad Laboratories (BIO) United States $10.234B 54.86
Insulet (PODD) United States $9.431B 558.86
Perrigo (PRGO) Ireland $7.400B 13.63
Canopy Growth (CGC) Canada $7.222B 0.00
Hill-Rom Holdings (HRC) United States $6.830B 20.36
Haemonetics (HAE) United States $6.455B 48.71
William Demant Holdings (WILYY) Denmark $5.988B 0.00
GN STORE NORD (GNNDY) Denmark $5.344B 27.61
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Aurora Cannabis (ACB) Canada $4.002B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.680B 0.00
Neogen (NEOG) United States $3.490B 58.40
NuVasive (NUVA) United States $3.398B 27.09
ICU Medical (ICUI) United States $3.237B 21.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.634B 0.00
Quidel (QDEL) United States $2.510B 24.93
Agios Pharmaceuticals (AGIO) United States $1.982B 0.00
National Vision Holdings (EYE) United States $1.877B 40.51
Cardiovascular Systems (CSII) United States $1.670B 0.00
Aphria (APHA) $1.242B 0.00
VAREX IMAGING (VREX) United States $1.124B 25.90
AtriCure (ATRC) United States $1.059B 0.00
Phibro Animal Health (PAHC) United States $0.867B 14.10
Eagle Pharmaceuticals (EGRX) United States $0.854B 21.78
NanoString Technologies (NSTG) United States $0.787B 0.00
Omeros (OMER) United States $0.759B 0.00
Lantheus Holdings (LNTH) United States $0.734B 19.29
PetIQ (PETQ) United States $0.725B 17.13
LeMaitre Vascular (LMAT) United States $0.689B 40.82
Cerus (CERS) United States $0.624B 0.00
Surmodics (SRDX) United States $0.621B 118.00
MacroGenics (MGNX) United States $0.560B 0.00
Quanterix (QTRX) United States $0.548B 0.00
TG Therapeutics (TGTX) United States $0.530B 0.00
OraSure Technologies (OSUR) United States $0.523B 24.23
Owens & Minor (OMI) United States $0.459B 13.76
Meridian Bioscience (VIVO) United States $0.427B 13.32
Zynex (ZYXI) United States $0.346B 36.76
BioLife Solutions (BLFS) United States $0.339B 104.19
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.327B 0.00
Bovie Medical (APYX) United States $0.234B 0.00
United Health Products (UEEC) United States $0.208B 0.00
Vapotherm (VAPO) United States $0.177B 0.00
Repro-Med Systems (REPR) United States $0.158B 0.00
Rockwell Medical (RMTI) United States $0.153B 0.00
Cytosorbents (CTSO) United States $0.147B 0.00
Female Health (VERU) United States $0.138B 0.00
Fonar (FONR) United States $0.133B 9.32
InfuSystems Holdings (INFU) United States $0.127B 0.00
Liberty Health Sciences (LHSIF) Canada $0.104B 0.00
Chembio Diagnostics (CEMI) United States $0.097B 0.00
Chimerix (CMRX) United States $0.088B 0.00
Nephros (NEPH) United States $0.087B 0.00
United-Guardian (UG) United States $0.084B 19.82
MTech Acquisition (KERN) United States $0.063B 0.00
MRI Interventions (MRIC) United States $0.058B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.053B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
Surface Oncology (SURF) United States $0.039B 0.00
Senestech (SNES) United States $0.023B 0.00
Trinity Biotech (TRIB) Ireland $0.020B 0.00
GUARDION HEALTH (GHSI) United States $0.018B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.013B 0.00
Myomo (MYO) United States $0.010B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00